All News

Sandoz announced that Zarxio (filgrastim-sndz), the first biosimilar approved by the FDA in March, is now available in the United States.

Close the pharmacy

Guest columnist The Cynical Pharmacist offers a proposal every retail pharmacist will love.

Now that a judge has granted conditional class certification to a lawsuit claiming Walmart failed to compensate pharmacists for some time related to immunization training, the lead plaintiff is urging her former colleagues to join the litigation.

CVS Health recently introduced a new pharmacy service, ScriptSync, designed to enable patients with multiple Rxs to pick them up during one visit to the pharmacy.

Patients with poorly controlled type 2 diabetes (T2DM) experienced a significant decline in their HbA1c levels when adding Technosphere inhaled insulin (Afrezza, MannKind Corp.) to their current treatment regimen, according to a new study.

CVS/Caremark and Express Scripts, the two biggest players in the pharmacy benefits management industry, have both added medications to their exclusion lists.